Krv Labs
EXAMPLE USE CASES

Concrete work, not abstract scores.

01 / Pulsar

Rare-disease trial matching

Find phenotype segments and missing screening signals before manual chart review.

Explore Pulsar
02 / Pasteur

Hospital model signoff

Map where a clinical decision-support model should be trusted, flagged, or blocked.

Explore Pasteur
03 / Topos

Agent engineering governance

Catch insecure or structurally weak generated code before merge.

Explore Topos
THE OPERATING ENVELOPE

Average-case accuracy is not a safety claim.

A benchmark is an average over a frozen test set. Deployed agents meet rare inputs, drift, and chain decisions across dozens of steps.

WHAT A SINGLE NUMBER HIDES

A strong overall score can still hide the cases that matter most. Epic's sepsis model passed its vendor benchmark, then scored just 0.63 AUC in external validation — missing 67% of sepsis patients. We surface the subgroups where accuracy collapses.

Test sets are frozen; the world keeps moving — missing labs, new workflows, a shifted population. Deployed agents routinely show a ~37% gap between benchmark and real-world performance.

A 95%-accurate step is only 59%reliable over ten steps — error compounds with every tool call. It's one reason 78% of agentic pilots stall before production.

Models pass benchmarks through shortcuts they can't repeat live, overstating real reliability by 20–40%. We check the structure behind a decision, not just whether the output matched.

The job is to show exactly where a system is safe, where it should be flagged, and where it must be blocked — as evidence a governance committee or auditor can act on.

We started where being wrong costs a life — the same mathematics maps the boundary wherever mistakes are expensive.

GET STARTED

Bring proof to your agents.

The methods behind Krv are peer-reviewed and field-tested well beyond healthcare — including work published in Nature Energy. See what they reveal about your data, models, and code.

Clinical AIDrug DiscoveryEnergy SystemsAgent Code